Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Ранг среди акций #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Цена акции
$41.14
Последняя синхронизация: 2026-09-21
Рыночная капитализация
$182.76B
Изменение (1 день)
-7.78%
Изменение (1 год)
-32.24%
Страна
DK
Торговля Novo Nordisk A/S (NOVO-B)

Категория

Коэффициент P/B для Novo Nordisk A/S (NOVO-B)
Коэффициент P/B на September 2026 TTM: 5.61
Согласно последним финансовым отчетам и цене акций Novo Nordisk A/S, текущий коэффициент P/B (TTM) составляет 5.61. В конце 2024 он составлял 19.38.
История P/B для Novo Nordisk A/S с 2000 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) 5.61 -24.68%
2025 7.45 -61.56%
2024 19.38 -34.02%
2023 29.37 15.39%
2022 25.45 6.65%
2021 23.87 51.77%
2020 15.72 -1.35%
2019 15.94 12.22%
2018 14.20 -14.34%
2017 16.58 16.48%
2016 14.23 -34.97%
2015 21.89 29.23%
2014 16.94 35.36%
2013 12.51 -0.67%
2012 12.60 26.42%
2011 9.97 0.88%
2010 9.88 77.44%
2009 5.57 9.91%
2008 5.07 -20.41%
2007 6.36 25.26%
2006 5.08 20.40%
2005 4.22 11.39%
2004 3.79 16.59%
2003 3.25 4.96%
2002 3.10 -47.14%
2001 5.86 -4.54%
2000 6.14 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
29.9692 434.10%
US
7.6479 36.30%
US
-78.0908 -1,491.70%
US
8.4776 51.08%
CH
8.5385 52.17%
US